The subject invention concerns novel materials and methods for the detection of human osteoarthritis and cancer. Specifically, a human HtrA gene and gene product are disclosed which are differentially expressed when comparing osteoarthritic tissue to non-osteoarthritic tissue. A further aspect of the invention concerns compounds which antagonize the biological activity of HtrA protein and methods for identifying these compounds. Another aspect of the present invention concerns pharmaceutical compositions comprising such compounds.
